Valsartan might have delayed the onset of new diabetes but did not demonstrate any independent cardioprotective advantage over amlodipine at the studied dosage. Julius S et al. Outcomes in ...
Organically Human on MSN4mon
Blood pressure medication was recalled because it may give you cancer insteadThe recall list is long, covering valsartan prescriptions in a number of different dosages and amounts. A number of different ...
The dual-action agent LCZ696 blocks the angiotensin II receptor (via a valsartan moiety) and inhibits neprilysin (via an AHU377 moiety). In a phase II trial, this drug “demonstrated superior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results